ERBB2 and gastric cancer: T-DM1 caused rapid tumor shrinkage of human gastric cancer xenografts with high HER2 expression (IHC 3+), the type of cell death being predominantly apoptosis [17], whereas T-DM1 was less effective on human breast cancer xenografts expressing moderate HER2 levels (IHC 2+), but prolonged treatment times eventually evoked apoptosis and mitotic catastrophe in these xenografts [18].